Innovative Dosage Forms for Esophageal Drug Delivery
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 10 July 2024 | Viewed by 62
Special Issue Editors
Interests: oral drug delivery; biopharmaceutics; pharmakokinetics
Special Issues, Collections and Topics in MDPI journals
Interests: oral drug delivery; biopharmaceutics; pharmakokinetics; 3d printing
Special Issue Information
Dear Colleagues,
The increasing clinical interest in advanced and innovative delivery systems for targeted therapy of the esophagus is driven by the rising prevalence of several diseases such as esophagitis, GERD, Barrett’s esophagus and esophageal cancer in recent years. Addressing this demanding therapeutic challenge requires not only advances in formulation and device development, but also the advancement of modern pharmaceutical processes and technical solutions to enable precise biopharmaceutical causal drug targeting. The development of novel test methods for the pharmacokinetic and pharmacodynamic evaluation of new therapeutic concepts for the esophagus is also of great interest for this issue.
As guest editors, we invite researchers to submit their work for the Special Issue of Pharmaceutics entitled “Innovative Dosage Forms for Esophageal Drug Delivery”, which will address all multidisciplinary approaches that contribute to overcoming the complex challenge of targeted pharmacotherapy in the esophagus. Both research papers and reviews are welcome for publication.
We look forward to receiving your contributions.
Prof. Dr. Werner Weitschies
Dr. Julius Krause
Dr. Christoph Rosenbaum
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- esophagus
- drug targeting
- advanced drug delivery
- esophagitis
- gastroesophageal reflux disease
- barrett’s esophagus
- esophageal cancer
- biorelevant dissolution
